Status:
COMPLETED
Tolerability of ALK Grass Tablet in Children
Lead Sponsor:
ALK-Abelló A/S
Conditions:
Allergy
Eligibility:
All Genders
5-12 years
Phase:
PHASE1
Brief Summary
The purpose of this trial is to assess whether the ALK Grass tablet treatment is safe to use in children aged 5-12 years
Eligibility Criteria
Inclusion
- Grass pollen induced rhinoconjunctivitis
- Boys and girls, 5-12 years of age
- Positive skin prick test to grass pollen
Exclusion
- Severe asthma
- Previous treatment with immunotherapy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00310453
Start Date
March 1 2006
End Date
May 1 2006
Last Update
May 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Alergia, Hospital del Niño Jesús
Madrid, Spain, 28040